FABP4 Human, His

Fatty Acid Binding Protein 4 Human Recombinant, His Tag
Shipped with Ice Packs
In Stock

Description

Introduction to FABP4

Fatty Acid-Binding Protein 4 (FABP4), also known as adipocyte FABP (A-FABP) or aP2, is a cytoplasmic lipid chaperone primarily expressed in adipocytes and macrophages . It plays a pivotal role in regulating lipid metabolism, inflammatory responses, and cellular signaling pathways . Elevated circulating FABP4 levels are strongly associated with metabolic disorders (e.g., obesity, insulin resistance, type 2 diabetes) and cardiovascular diseases, including atherosclerosis and hypertension .

FABP4 Human, His – Definition and Production

FABP4 Human, His refers to a recombinant human FABP4 protein engineered with a polyhistidine (His) tag for purification and research applications. Key features include:

PropertyDetail
Expression SystemTypically produced in E. coli or mammalian cell lines .
TagC-terminal or N-terminal hexahistidine tag for affinity chromatography .
Molecular Weight~15 kDa (calculated based on 132-amino acid sequence) .
FunctionRetains native binding affinity for fatty acids (e.g., linoleic acid) and eicosanoids .

This recombinant protein is widely used in biochemical assays, structural studies, and drug discovery .

Key Functional Interactions

TargetEffect of FABP4 InteractionCitation
PPARγTriggers ubiquitination and proteasomal degradation .
JAK2Attenuates signaling via direct binding .
Endothelial CellsInhibits nitric oxide synthase, promoting dysfunction .

The His tag does not interfere with ligand binding or protein-protein interactions in validated assays .

Table 1: Key Studies Utilizing Recombinant FABP4

Study FocusFindingsCitation
Cancer MetastasisFABP4 enhances ovarian cancer cell migration and invasion in vitro .
Therapeutic InhibitionBMS309403 (FABP4 inhibitor) reduces atherosclerosis in mice .
DiabetesFABP4-neutralizing antibodies correct hyperglycemia in obese mice .
Renal ClearanceCirculating FABP4 is eliminated via glomerular filtration .

Biomarker Potential

  • Circulating FABP4 levels predict cardiovascular mortality (HR: 4.96 for highest tertile) .

  • Elevated FABP4 correlates with left ventricular dysfunction and carotid atherosclerosis .

Therapeutic Targeting

  • Small-Molecule Inhibitors: BMS309403 blocks fatty acid binding, improving insulin sensitivity .

  • Monoclonal Antibodies: Humanized anti-FABP4 antibodies (e.g., 12G2) suppress tumor growth in breast cancer models .

Future Directions

FABP4’s dual role in metabolic regulation and inflammation positions it as a multifaceted therapeutic target. Ongoing research focuses on:

  • Developing isoform-specific inhibitors to minimize off-target effects .

  • Exploring FABP4’s role in cancer stemness and mitochondrial metabolism .

Product Specs

Introduction
Adipocyte fatty acid binding protein FABP4, a 15 kDa protein, belongs to the intracellular fatty acid binding protein (FABP) family. This family is known for binding fatty acids and similar compounds (like bile acids or retinoids) within an internal cavity. The expression of FABP4 in adipocytes depends on their differentiation stage and plays a crucial role in regulating these cells' biological functions. Studies in mice show that targeted mutations in FABP4 offer significant protection against hyperinsulinemia and insulin resistance in both dietary and genetic obesity. Adipocytes lacking FABP4 exhibit reduced ipolysis efficiency both in vitro and in vivo, and these mice displayed moderately improved systemic dyslipidemia. Recent research also revealed FABP4 expression in macrophages during their differentiation and activation. In these cells, FABP4 influences inflammatory responses and cholesterol ester buildup. Notably, total or macrophage-specific FABP4 deficiency provides substantial protection against atherosclerosis in apoE-/- mice. These findings point to a central role of FABP4 in developing major metabolic syndrome components through its distinct actions in adipocytes and macrophages.
Description
Recombinant human FABP4, produced in E. coli, is a single, non-glycosylated polypeptide chain. It consists of 132 amino acids, resulting in a molecular weight of 18 kDa. The protein includes a His tag fused at the N-terminus and is purified using standard chromatography techniques.
Physical Appearance
The product is a clear, colorless liquid solution that has been sterilized by filtration.
Formulation
FABP4 His-Tag is supplied in a buffer solution containing 20mM Tris HCL (pH 8), 0.5mM DTT, and 50% glycerol.
Stability
For short-term storage (up to 4 weeks), the product should be kept refrigerated at 4°C. For long-term storage, it is recommended to freeze the product at -20°C. Avoid repeated freeze-thaw cycles to maintain product integrity.
Purity
The purity of the FABP4 protein is greater than 95% as determined by SDS-PAGE analysis.
Synonyms
Fatty acid-binding protein adipocyte, AFABP, Fatty acid-binding protein 4, Adipocyte lipid-binding protein, ALBP, A-FABP, FABP4.
Source
Escherichia Coli.

Q&A

Basic Research Questions

  • What is the primary function of FABP4 in human metabolism?

    FABP4 primarily facilitates fatty acid transport across cellular membranes, playing a crucial role in lipid metabolism. It binds to long-chain fatty acids and participates in their intracellular trafficking. Beyond simple transport, FABP4 is involved in glucose metabolism regulation, with studies demonstrating its direct regulation of hepatic glucose synthesis by increasing the expression of gluconeogenic enzymes including glucose-6-phosphatase and phosphoenolpyruvate carboxykinase 1 . Methodologically, researchers can investigate FABP4's metabolic functions through knockout mouse models, which show altered lipid profiles with increased short-chain fatty acids and decreased long-chain fatty acids .

  • How does FABP4 expression differ between genders and age groups?

    Studies reveal significant gender and age-related differences in FABP4 expression. Research from the Kuwait Diabetes Epidemiology Program demonstrated significantly higher FABP4 concentrations in female participants compared to males (18.8 ng/mL vs. 14.4 ng/mL, p < 0.001) . Additionally, individuals over 50 years old exhibited higher concentrations than those under 50 (19.3 ng/mL vs. 16.2 ng/mL, p < 0.001) . Multivariate regression analysis confirmed these associations, with FABP4 levels negatively associated with male gender (β: −3.85, 95% CI: −4.92, −2.77, p < 0.001) and positively associated with age (β: 0.14, 95% CI: 0.096, 0.183, p < 0.001) . These differences must be considered when designing research studies and interpreting FABP4 data.

  • What relationships exist between FABP4 and markers of obesity?

    FABP4 demonstrates strong positive correlations with multiple obesity markers. Current research has established significant associations between FABP4 levels and BMI (r = 0.496, p < 0.001), hip circumference (r = 0.463, p < 0.001), and waist circumference (r = 0.436, p < 0.001) . These associations remain significant even after adjusting for age, gender, and ethnicity. Methodologically, researchers can assess these relationships through multivariate regression analysis while controlling for demographic variables. The table below summarizes key correlations between FABP4 and obesity markers:

    Obesity MarkerCorrelation Coefficient (r)p-value
    BMI0.496<0.001
    Hip Circumference0.463<0.001
    Waist Circumference0.436<0.001
  • How is FABP4 associated with glycemic indices?

    FABP4 shows significant positive associations with multiple glycemic indices, making it relevant for diabetes research. Analysis reveals positive correlations between FABP4 and HbA1c (r = 0.126, p < 0.001), fasting blood glucose (r = 0.184, p < 0.001), fasting insulin (r = 0.326, p < 0.001), and HOMA-IR (r = 0.333, p < 0.001) . When investigating these relationships, researchers should employ multivariate statistical approaches to account for confounding variables such as obesity metrics, as FABP4's relationship with glycemic control may be partially mediated by adiposity.

Product Science Overview

Structure and Function

FABP4 is composed of a β-barrel structure that forms the lipid-binding site, and two α-helices that act as a lid on the β-barrel . This structure allows FABP4 to bind long-chain fatty acids and retinoic acid, facilitating their transport and metabolism within cells . The protein plays a crucial role in lipid transport, metabolism, insulin resistance, and angiogenesis .

Expression and Regulation

The expression of FABP4 is induced by long-chain fatty acids and peroxisome proliferator-activated receptor γ (PPARγ) agonists . It is involved in various metabolic processes, and its dysregulation is associated with several metabolic disorders. For instance, knockout studies in mice have shown that the absence of FABP4 prevents the development of atherosclerosis and increases insulin sensitivity .

Clinical Significance

Elevated levels of FABP4 have been observed in patients with conditions such as colorectal cancer and rheumatoid arthritis . This makes FABP4 a potential biomarker for these diseases. Additionally, its role in metabolic processes makes it a target for therapeutic interventions aimed at treating metabolic disorders.

Recombinant FABP4

Recombinant human FABP4, tagged with a His tag, is produced in Escherichia coli (E. coli) and is typically used in research applications such as ELISA, Western blot (WB), and immunoprecipitation (IP) . The His tag facilitates the purification of the protein using standard chromatography techniques . This recombinant protein retains the functional properties of the native protein, making it a valuable tool for studying the biological functions and interactions of FABP4.

Applications

Recombinant FABP4 is used in various research applications to study its role in lipid metabolism and its potential as a therapeutic target. It is also used in assays to investigate its binding properties and interactions with other molecules .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.